|
| Exchange Disseminated Time 12/08/2016 14:15:26 | Sun Pharmaceutical Industries Ltd has announced the following results for the quarter ended June 30, 2016:
The Unaudited Standalone results for the Quarter ended June 30, 2016
The Company has posted a net loss of Rs. (1514.60) million for the quarter ended June 30, 2016 as compared to net loss of Rs. (3963.50) million for the quarter ended June 30, 2015. Total Income has decreased from Rs. 21036.70 million for the quarter ended June 30, 2015 to Rs. 19047.00 million for the quarter ended June 30, 2016.
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended June 30, 2016
The Group has posted a net profit after taxes, minority interest and share of profit of associates and joint ventures of Rs. 20337.10 million for the quarter ended June 30, 2016 as compared to Rs. 5559.00 million for the quarter ended June 30, 2015. Total Income has increased from Rs. 69256.00 million for the quarter ended June 30, 2015 to Rs. 84000.90 million for the quarter ended June 30, 2016. |
|
|